EQS-News: MEDICLIN invites you to the 2026 virtual press conference on the financial statements for the year 2025
|
EQS-News: MEDICLIN AG
/ Key word(s): Conference/Miscellaneous
PRESS RELEASE
Press conference MEDICLIN invites you to the 2026 virtual press conference on the financial statements for the year 2025 Offenburg, 19 March 2026 – MEDICLIN Aktiengesellschaft (Ticker: MED; WKN 659 510) invites you to its 2026 virtual press conference on the financial statements fort the year 2025. The event will take place on Friday, 27 March 2026 at 11.00 am (CET). The Management Board of MEDICLIN will report on the 2025 financial year, current developments at MEDICLIN and the outlook for 2026 in a webcast. Following the presentation by the Management Board, you will have the opportunity to ask questions. The presentation will be held in German. To participate in the press conference, please register at the following link (German only): MEDICLIN virtual press conference on the financial statements for the year 2023 You will then receive the link to the webcast and the dial-in details for the telephone conference. Please note that whilst the webcast provides an audio feed via your internet browser, you will need to dial in by telephone to actively participate and ask questions. Please dial in 10 minutes before the start of the event. The replay of the webcast (without the Q&A session) will be available on the MEDICLIN website soon after the press conference. We look forward to your participation. CONTACT Head of Investor Relations and Sustainability Ender Gülcan | T. +49 781488326 | ender.guelcan@mediclin.de MEDICLIN AG | Okenstraße 27 | 77625 Offenburg MEDICLIN Aktiengesellschaft is one of Germany’s leading healthcare providers, with a clear focus on medical rehabilitation. MEDICLIN operates 31 clinics, six long-term care facilities, and ten medical care centers across Germany. MEDICLIN employs approximately 9,900 people. Through a strong network, MEDICLIN offers integrated care ranging from the initial doctor’s visit through surgery and subsequent rehabilitation to outpatient follow-up care. Medical and therapeutic staff, as well as nursing staff, work together in close coordination. MEDICLIN tailors the care and support provided to people in need of care to their individual needs and personal requirements. MEDICLIN is a company of the ASKLEPIOS Group.www.mediclin.de
19.03.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | MEDICLIN AG |
| Okenstraße 27 | |
| 77652 Offenburg | |
| Germany | |
| Phone: | +49 (0)781 488-326 |
| Fax: | +49 (0)781 488-184 |
| E-mail: | ender.guelcan@mediclin.de |
| Internet: | www.mediclin.de |
| ISIN: | DE0006595101 |
| WKN: | 659510 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX |
| EQS News ID: | 2294652 |
| End of News | EQS News Service |
|
|
2294652 19.03.2026 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | ||
| Sales1 | 659,86 | 673,14 | 704,70 | 730,07 | 748,75 | 778,00 | 0,00 | |
| EBITDA1,2 | 77,50 | 85,22 | 90,92 | 98,73 | 103,77 | 115,00 | 0,00 | |
| EBITDA-Margin3 | 11,75 | 12,66 | 12,90 | 13,52 | 13,86 | 14,78 | 0,00 | |
| EBIT1,4 | 0,15 | 11,56 | 19,52 | 12,72 | 53,49 | 63,00 | 0,00 | |
| EBIT-Margin5 | 0,02 | 1,72 | 2,77 | 1,74 | 7,14 | 8,10 | 0,00 | |
| Net Profit (Loss)1 | -0,04 | 1,49 | 9,72 | -10,72 | 24,91 | 35,00 | 0,00 | |
| Net-Margin6 | -0,01 | 0,22 | 1,38 | -1,47 | 3,33 | 4,50 | 0,00 | |
| Cashflow1,7 | 118,69 | 81,97 | 34,64 | 78,00 | 50,57 | 74,00 | 0,00 | |
| Earnings per share8 | -0,19 | 0,03 | 0,20 | -0,23 | 0,52 | 0,74 | 0,65 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,04 | 0,04 | 0,04 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: KPMG
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Mediclin | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 659510 | DE0006595101 | AG | 164,35 Mio € | 06.12.2000 | Kaufen | 8FW9FWGV+63 |
| PE 2027e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 5,58 | 15,78 | 0,35 | 15,66 | 0,67 | 2,04 | 0,22 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,04 | 0,04 | 1,16% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 28.06.2026 | 04.05.2026 | 30.07.2026 | 04.11.2025 | 27.03.2026 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| -7,88% | +2,70% | -6,49% | +19,31% | -68,55% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
